Allecra Therapeutics Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $10.6M
Latest Deal Amount
  • Investors
  • 7

Allecra Therapeutics General Information

Description

Developer of novel antibiotics designed to combat gram-negative bacterial infections. The company's novel antibiotics are used to treat multi drug resistant infections and overcome emerging resistance mechanisms thereby saving lives of patients whose infections may otherwise may be inadequately treated, enabling healthcare providers to cure bacterial infections efficiently.

Contact Information

Website
www.allecra.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Pharmaceuticals
Biotechnology
Primary Office
  • Wallbrunnstraße 24
  • 79539 Lörrach
  • Germany
+49 0761 00000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Allecra Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 04-Dec-2017 $10.6M 0000 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 20-May-2016 0000 000.00 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 18-Apr-2013 $19.4M $19.4M 000.00 Completed Startup
To view Allecra Therapeutics’s complete valuation and funding history, request access »

Allecra Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of novel antibiotics designed to combat gram-negative bacterial infections. The company's novel antibiotics ar
Drug Discovery
Lörrach, Germany
9 As of 2021
0000
00.00 0000-00-00
0000000000 0 0000

000000 0

lamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in vol
0000 000000000
San Diego, CA
00 As of 0000
00000
000000&0 00000

00000000

sequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
0000 000000000
Basel, Switzerland
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Allecra Therapeutics Competitors (36)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amplyx Pharmaceuticals Formerly VC-backed San Diego, CA 00 00000 000000&0 00000
000000000 Venture Capital-Backed Basel, Switzerland 00 000.00 000000000 000.00
0000000 0000000000 Venture Capital-Backed Altrincham, United Kingdom 0 0000000000 0
000000000 Venture Capital-Backed Berlin, Germany 0 000.00 00000000000 000.00
000 000000000 Venture Capital-Backed Bellshill, United Kingdom 0 000.00 0000000000 0 000.00
You’re viewing 5 of 36 competitors. Get the full list »

Allecra Therapeutics Executive Team (11)

Name Title Board Seat Contact Info
Andreas Kranzusch Chief Financial Officer & Managing Director
Stefano Biondi MD Head of Preclinical Development
Patrick Velicitat MD Chief Medical Officer
You’re viewing 3 of 11 executive team members. Get the full list »

Allecra Therapeutics Board Members (11)

Name Representing Role Since
Engelbert Willink MD Self Chairman 000 0000
Henry Chen JD Delos Capital Partners Board Member 000 0000
Holger Reithinger Ph.D Forbion Board Member 000 0000
Iain Buchanan Self Board Member 000 0000
Jason Rushton Xeraya Capital Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Allecra Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Allecra Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioMedPartners Venture Capital Minority 000 0000 000000 0
Xeraya Capital Venture Capital Minority 000 0000 000000 0
Delos Capital Partners Venture Capital Minority 000 0000 000000 0
Andera Partners PE/Buyout Minority 000 0000 000000 0
EMBL Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »